|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.738 CHF | -8.81% |
|
-10.26% | -17.22% |
| Apr. 11 | Swiss Market Index Falls as ECB Signals June Rate Cut | MT |
| Apr. 11 | Idorsia to Revise July 2024 Convertible Bond Terms, Conditions | MT |
Jan 10 (Reuters) - Swiss drugmaker Idorsia said on Monday it has received the U.S. Food and Drug Administration's approval for its treatment for insomnia in adult patients.
(Reporting by Mrinalika Roy and Akriti Sharma in Bengaluru; Editing by Sherry Jacob-Phillips)
| 1st Jan change | Capi. | |
|---|---|---|
| -17.22% | 373M | |
| -2.21% | 104B | |
| +1.90% | 97.42B | |
| +1.22% | 22.2B | |
| -17.94% | 21.23B | |
| -11.00% | 18.33B | |
| -42.33% | 16.35B | |
| -18.46% | 15.06B | |
| +5.24% | 13.98B | |
| +27.20% | 11.66B |
IDORSIA LTD 
